Medical Research Wiki

UC/Proctitis Methods and Protocols

Properties1
tagsulcerative-colitis, ulcerative-proctitis, methods, protocols, diet, supplements, remission

6 min read

UC/Proctitis Methods and Protocols

This page tracks possible remedies, remission strategies, protocols, and methods. Inclusion here means “worth indexing,” not “recommended.”

Current method categories to build out

Trigger removal / elimination

  • Dairy elimination / component testing — high priority due to Paul’s rapid bleeding response. Treat as a research/tracking and clinician-discussion branch, not proof that milk allergy universally causes UC. See Wheat Food-Trigger Mechanisms in UC and Non-IgE Dairy Hypersensitivity in UC.
  • Gluten/wheat elimination or testing-guided avoidance — clarify celiac vs non-celiac gluten sensitivity vs wheat/fructan/FODMAP sensitivity. See Wheat Food-Trigger Mechanisms in UC.
  • Processed foods/emulsifiers/additives.
  • High-sulfur foods or oxidative stressors if supported by sources.

Diet frameworks

  • Whole-food plant-based / high-carb / High Carb Health style.
  • Carnivore / keto / lion diet as elimination strategy — noteworthy anecdotal/case-report responder signal, but unresolved mechanism and safety/tolerability questions. The 2026-06-28 Grok/X triage found social remission claims plus a 2024 10-patient IBD carnivore-keto case series and a 2025 single-patient ketogenic UC remission case report; treat as a clinician/dietitian-discussion elimination/ketosis/contact-time question, not a proven protocol. See Nicotine X Anecdotes — Quick Triage.
  • Ray Peat/metabolic/endotoxin-informed diet ideas.
  • Low-FODMAP or targeted fermentation reduction.
  • 4-SURE / reduced-sulfide functional microenvironment diet — promising UC-specific research branch targeting H₂S, indole/protein fermentation, SCFA balance, and sulfur metabolism; evidence remains open-label/early and should be clinician/dietitian-guided, especially because fiber/resistant starch can worsen UC-associated constipation/contact time. See Functional Distal Microenvironment in UC Proctitis.
  • SCD/GAPS/IBD-AID style approaches.

Redox / oxidative stress protocols

  • Dr. Pravda theory — useful mechanistic hypothesis, not a standalone treatment directive. See Thiolase Branch in UC.
  • RDLA / R-dihydrolipoic acid — clinician-discussion/research-only; supplement authenticity/quality is a major issue.
  • Sodium thiosulfate — clinician-supervised research question only; do not treat as DIY enema protocol.
  • Antioxidant/enema theories — safety-filter carefully. Hydrogen peroxide enemas and chlorine dioxide/CDS/MMS are explicit danger/avoid categories.

Microbiome and gut ecology

  • Probiotics — strain/formulation-specific; strongest UC maintenance signal so far is E. coli Nissle 1917, while De Simone/original VSL#3/Visbiome-style products have active-UC signals with product-identity caveats. See Butyrate Ecology in UC.
  • Prebiotics — potentially useful for F. prausnitzii/Roseburia/butyrate ecology, but must be balanced against UCAC/contact-time tolerance.
  • Functional microenvironment tracking — when evaluating diet/protein/fiber/prebiotic changes, track not just symptoms but mucus, blood, stool form, straining, incomplete evacuation, tenesmus, gas/bloating, and calprotectin if available. See UC Functional Distal Microenvironment — Scite-Heavy Research Pass.
  • Psyllium / Plantago ovata — small UC remission-maintenance trial signal plus strongest general constipation-fiber evidence; clinician-guided, slow/tolerability-focused evaluation only, because flatulence/UCAC worsening is possible.
  • Fermented foods — index separately from probiotic RCT evidence; product/strain and tolerance matter.
  • FMT — clinician-supervised only; donor-screening/infection risks.
  • Pathobiont-targeted approaches — clinician/research-only; see Microbial Positioning in UC.
  • Stool testing-guided protocols — use cautiously; stool may not capture mucosa-associated organisms, epithelial contact, or toxins such as aerolysin/FadA.
  • Oral-gut/periodontal tracking if Fusobacterium/oral pathobiont branch remains relevant.

Nervous system / stress / sleep

  • Mind-Gut Immunity Clinic protocol.
  • Trauma/stress/nervous-system approaches.
  • Meditation/breathing/vagal work.
  • Sleep apnea treatment / sleep-quality optimization / circadian stabilization as inflammation and barrier-reserve support. See Circadian Disruption as UC Barrier Amplifiers.

Supplements and compounds to assess

  • Curcumin/turmeric.
  • Berberine — small phase I UC/dysplasia trial signal with mesalamine background and improved Geboes histology grade, but tiny sample and liver-enzyme/interactions caveats. See UC Supplement Shortlist — Berberine, Omega-3, Liposomal Glutathione.
  • Qing Dai.
  • Nicotine — older RCT/Cochrane evidence suggests transdermal nicotine can outperform placebo for induction in active mild-to-moderate UC, but it was not better than standard therapy, not useful as maintenance in an NEJM trial, and adverse events/withdrawals were common. Clinician-supervised discussion only; addiction/cardiovascular/sleep/anxiety risks matter. See Nicotine X Anecdotes — Quick Triage.
  • Phosphatidylcholine / delayed-release PC / mucus-PC barrier repair — promising but formulation-specific and contested after LT-02 results. See Delayed-Release PC Barrier Repair in UC.
  • Butyrate — mechanistically central but direct butyrate/SCFA enema evidence is mixed; see Butyrate Ecology and Thiolase Branch in UC.
  • NAC / glutathione / liposomal glutathione — redox-support branch. Direct liposomal glutathione UC trial evidence was not found in the 2026-06-28 quick pass; NAC has more direct UC remission-maintenance evidence and should be the clinician-discussion comparator. See Thiolase Branch in UC and UC Supplement Shortlist.
  • Omega-3 / fish oil / Juice+ Omega-type blends — mixed UC evidence: possible inflammation/active-disease biomarker benefit, weak maintenance-remission evidence, and GI/bleeding/reflux/product-quality caveats. Verify the exact product label and EPA/DHA dose before judging. See UC Supplement Shortlist.
  • Vitamin D.
  • Minerals/electrolytes.
  • Herbal protocols from Notion source queue.

Contact-time / pelvic-floor / local mechanics

  • UC-associated constipation / fecal stasis / stool contact-time reduction — clinician-guided; see Pelvic Floor Mechanics in UC Proctitis.
  • Pelvic floor PT / biofeedback / anorectal evaluation — clinician-discussion question when incomplete evacuation, tenesmus, obstructed defecation, or rectal pain persist.
  • Fiber/laxative/prokinetic approaches — do not use generic advice; UCAC reviews warn some patients worsen with fiber and active inflammation/obstruction risk must be considered. See Full-Evacuation Strategy in UC Proctitis.
  • Kiwi / kiwifruit — promising food-based chronic-constipation signal with low adverse-event/dissatisfaction in one comparative trial; not UC-specific and needs tolerance tracking.
  • PHGG / partially hydrolyzed guar gum — possible gentler prebiotic; constipation evidence weaker and not UC-specific.
  • PEG / non-fermentative osmotic options — guideline-backed clinician-discussion path when fiber/prebiotics worsen gas or retention.

Conventional/local therapies to contextualize

  • Current active care plan — see Proctitis Care Plan and Routine for Paul’s current mesalamine enema/suppository alternation and Dr. Snow supplement regimen tracking.
  • Mesalamine suppositories/enemas — evidence-based for distal disease/proctitis; see Pelvic Floor Mechanics in UC Proctitis.
  • Steroid foam/enemas.
  • Biologics/JAK/S1P options if relevant.
  • How local therapy interacts with root-cause/remedy search.

Evaluation template for each method

For each method/protocol, record:

  • Claim: cure, remission, symptom control, barrier healing, trigger avoidance?
  • Mechanism proposed.
  • Evidence level.
  • Anecdotal signal quality.
  • Relevance to Paul’s profile.
  • Safety flags.
  • Objective markers used in reports.
  • What would count as success/failure.
  • Clinician questions.

Scite validation method notes — 2026-06-27

From UC Central Theory Scite Validation Pass:

  • Future diet/fiber/microbiome methods should be judged by functional endpoints: mucus, blood, stool form, straining, incomplete evacuation, bloating/gas, calprotectin if available, and tolerability.
  • Avoid generic “more fiber” reasoning in Paul’s UCAC/contact-time pattern; fermentable substrates can help SCFA ecology but may worsen retention/gas/contact time.
  • 4-SURE-style sulfur/H₂S targeting is an interesting clinician-discussion research branch, not a self-directed cure protocol.
  • IAP/SRB/Snail and Aeromonas/aerolysin findings are mechanistic/pathobiont hypotheses; they do not justify DIY antibiotics, FMT, or antimicrobial/enema protocols.

Graph View

Backlinks